ArticleScientific reports2017

PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy.

Alberto Cruz-Bermúdez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.